Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer. Preliminary Report
Giancarlo Pizza1, C. De Vinci1, G. Lo Conte1, A. Mazzuca1, G. Corrado1, D. Menniti1, A. Benati1, P. Romagnoli1, V. Fornarola1, L. Busutti2, A. Palareti3, R. Capanna4, V. Di Maio1, S. Ratini1, A. Gulino5, A. Vacca5, L. Melchiorri6, M. Ferrari7, S. Boriani8, R. O. Baricordi6
1Immunotherapy Module, Operative Unit of Urology, Department of Urology and Nephrology, S. Orsola-Malpighi Hospital, Bologna, Italy 2Operative Unit of Radiotherapy, Department of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy 3Department of Computer Science, University of Bologna, Bologna, Italy 42nd Division of Orthopaedics and Reconstructive Surgery Centre, Florence, Italy 5Experimental Medicine, University "La Sapienza", Roma, Italy 6Department of Experimental and Diagnostic Medicine, Section of Medical Genetics, University of Ferrara, Ferrara, Italy 7Experimental Institute of Zoo-prophylaxis, Emilia-Romagna and Lombardia Regions, Brescia, Italy 8Operative Unit of Orthopaedics, Maggiore Hospital, Bologna, Italy
